Warfarin potentiation with bezafibrate.
Beringer
T R
TR
Department of Health Care for the Elderly, Royal Group of Hospitals, Belfast, Northern Ireland.
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D001629:Bezafibrate / Q000009:adverse effects*; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D019934:International Normalized Ratio; D008297:Male; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D000960:Hypolipidemic Agents; D014859:Warfarin; D001629:Bezafibrate